Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(33%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_2
2
33%
Ph phase_1
1
17%
Ph phase_4
2
33%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(2)

Detailed Status

Completed4
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 42 (33.3%)
N/A1 (16.7%)

Trials by Status

completed467%
terminated233%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_1

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

NCT00001644
completedphase_4

Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers

NCT00050180
completedphase_4

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

NCT00192660
completedphase_2

Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir

NCT00362310
terminatedphase_2

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

NCT00120783
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00001644Phase 1

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Completed
NCT00050180Phase 4

Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers

Completed
NCT00192660Phase 4

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Completed
NCT00362310Phase 2

Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir

Completed
NCT00120783Phase 2

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Terminated
NCT00122590Not Applicable

Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

Terminated

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6